After completing this course, participants will be able to:
- Discuss the clinical profile of young adult heart patients and differentiate between their inherited simple and complex congenital heart disease conditions.
- Describe the anomalies associated with cardiomyopathies and diseases of the vascular, coronary, and valvular systems.
- Examine the clinical characteristics of young adult heart patients with connective tissue disorders, and differentiate between the cardiovascular risks of these disorders, including those presenting in Loeys-Dietz, Marfan, and Ehler-Danlos syndromes.
- Identify genetic and familial factors in young adult heart disease patients with their inherent clinical manifestations, evidence-based management of the conditions, and genetic testing and counseling.
- Prescribe exercise and sports modifications, provide lifestyle recommendations, and manage pregnancy in the young adult heart patient to optimize lifelong health.
- Describe how to utilize medical devices and surgical therapies in the care of young adult heart patients.
- Discuss current and novel pharmacological approaches and associated therapeutic strategies to treat young adult heart conditions.
- Identify options for electrophysiological interventions to address young adult heart conditions.
topics
| Sr No | Runtime | Session Title |
|---|---|---|
| 1 | 02:12 | Mitral Valve Prolapse With Mitral Annular Disjunction: When Should Surgical Repair Be Considered? |
| 2 | 10:05 | Marfan Syndrome and Related Fibrillinopathies |
| 3 | 12:37 | Bicuspid Aortic Valve With or Without Aortopathy |
| 4 | 12:04 | Single Ventricle Physiology After Fontan Palliation |
| 5 | 10:32 | Hypertrophic Cardiomyopathy: Imaging, Genetics, and Sudden Death Prevention |
| 6 | 12:53 | Mitral Valve Disease in Young Adults |
| 7 | 10:10 | Arrhythmogenic and Dilated Cardiomyopathies |
| 8 | 09:28 | Congenital Heart Disease–Related Arrhythmias |
| 9 | 08:03 | Adult D-TGA After Mustard Repair |
| 10 | 12:30 | Electrophysiologic Sequelae of Structural Congenital Heart Disease |
| 11 | 14:52 | Channelopathies: Risk Prediction and Targeted Therapy |
| 12 | 13:56 | Preconception Counselling and Assessment of Women with Cardiac Disease |
| 13 | 13:39 | Cardio-Obstetrics Management of High-Risk Congenital Heart Disease |
| 14 | 19:05 | Postpartum Cardiovascular Recovery and Long-Term Follow-Up |
| 15 | 12:20 | Exercise Prescription in Cardiovascular Disease |
| 16 | 19:48 | From Athlete’s Heart to Heart Failure |
| 17 | 15:31 | Heritable Coronary Artery Disorders |
| 18 | 12:49 | TGF-beta Pathway Aortopathies and Loeys-Dietz Syndrome |
| 19 | 11:10 | Anomalous Coronary Artery Disease |
| 20 | 13:08 | Intervening on the Bicuspid Aortic Valve |
| 21 | 15:03 | Cardiovascular Genomics Q&A |
| 22 | 12:44 | Restrictive and Infiltrative Cardiomyopathies |
| 23 | 13:16 | Transposition of the Great Arteries |
| 24 | 19:05 | Tetralogy of Fallot |
| 25 | 11:10 | Coarctation of the Aorta |
| 26 | 11:58 | VSD & PDA: Spectrum, Hemodynamics, and Natural History |
| 27 | 15:02 | Surgical Management of Single Ventricle Physiology |
| 28 | 11:15 | PAPVR: Indications for Intervention and Repair |
| 29 | 20:50 | Adult Congenital Heart Disease Q&A |
| 30 | 40:11 | Managing Anomalous Coronary Arteries and Myocardial Bridges |
| 31 | 09:33 | Robotic Mitral Valve Repair |
| 32 | 14:42 | Atrial Fibrillation: Early Catheter Ablation |
| 33 | 11:16 | Long QT Syndrome in Athletes |
| 34 | 20:24 | Conduction System Disorders and Arrhythmogenic Cardiomyopathies |
| 35 | 13:26 | Atrial Septal Defects in Adults |
